Phase 2 Interim Data Evaluating the Combination of Pracinostat and Azacitidine in Patients with Myelodysplastic Syndrome Presented at the 2018 American Society of Hematology Annual Meeting

Phase 2 Interim Data Evaluating the Combination of Pracinostat and Azacitidine in Patients with Myelodysplastic Syndrome Presented at the 2018 American Society of Hematology Annual Meeting

LUGANO, Switzerland and San Diego, USA, December 3, 2018: Helsinn Group, a Swiss pharmaceutical group focused on building quality

Read More

ForgeRock Delivers Industry’s Fastest, Most Comprehensive and Developer-Friendly Identity Management Solution for Multi-Cloud Deployment

Features Pre-Defined Cloud Installation Packages – 1 Million, 10 Million and 100 Million – for Deployments in Minutes

LAS VEGAS, Dec. 03, 2018 (GLOBE NEWSWIRE) — ForgeRock again demonstrates innovation leadership by enabling near-instant deployment of its identity platform in multi-cloud environments. At Gartner IAM, …

Read More